Study reveals a novel activation mechanism for Ste2

  • March 16, 2022
Study reveals a novel activation mechanism for Ste2

Vaithish Velazhahan is first author of a Nature paper on the GPCR Ste2, with important implications for treating fungal diseases.

A Gates Cambridge Scholar has shed new light on an important G protein-coupled receptor [GPCR] which could help researchers to better understand and treat fungal diseases such as candidiasis and pulmonary aspergillosis.

GPCRs are membrane proteins which are essential for signal transduction and communicating with an organism’s surrounding environment. GPCRs are divided into six classes (A-F); Class D GPCRs are found exclusively in fungi and regulate fungal survival and reproduction.

Previous research by Gates Cambridge Scholar Vaithish Velazhahan [2018] determined the first ever structure of a fungal GPCR, using Ste2, a prototypical Class D1 GPCR which is essential for mating in the yeast Saccharomyces cerevisiae. Ste2 was found to form a homodimer and couple to two G proteins simultaneously, which provided the first insights into how a transmembrane-mediated GPCR dimer could form and interact with G proteins.

Vaithish, who is doing his PhD in Biological Science at the MRC Laboratory of Molecular Biology, is first author on a new paper, published in Nature, which takes that research forward and shows that Ste2 has a novel method of activation which is unique from mammalian GPCRs.

To capture Ste2 in its various conformations along the activation pathway, Vaithish used different peptide ligands, purifying the GPCR separately under each condition. To purify ligand-free Ste2, Vaithish developed a method called pre-stabilisation of a GPCR by weak association (PSGWAY). This method involves adding a purified wild type heterotrimeric protein, Gpa1-Ste4-Ste18, to help stabilise ligand-free Ste2 before its purification. Then electron cryomicroscopy (cryo-EM) was used to collect multiple datasets of different samples, involving over 32,000 micrographs in total.

Computational processing of the datasets led to the determination of four new Ste2 structures: a ligand-free state, an antagonist-bound state and two agonist-bound intermediate states. Their research highlights that Ste2 has a structural and activation mechanism distinct from all previously determined monomeric GPCRs.

Molecular dynamics simulations were then performed using these structures and revealed allosteric communication pipelines that differed between the various states. The study suggests ways in which allosteric communication within Ste2 may affect their activation which is also relevant to understanding allosteric communication across other transmembrane-mediated GPCR dimers in humans.

The research could have important implications as fungal diseases, such as invasive candidiasis and pulmonary aspergillosis, account for a major disease burden worldwide and cause life-threatening conditions in humans. In addition, they can threaten global food supply through crop infection. An improved understanding of fungal GPCRs can help to tackle these issues.

Due to their wide-ranging cellular functions, GPCRs are also critical to drug development, with approximately one third of all FDA-approved drugs targeting them. Understanding the activation method of Ste2 could encourage new possibilities for rational drug design. More specifically, the research may make it possible to specifically target fungal GPCR signalling without also inadvertently targeting human GPCRs. The researchers say such a fungal-specific means of drug development could help design medicines which avoid off-target effects and possible therapeutic side-effects.

The research was funded by UKRI MRC, the Gates Cambridge Trust and the National Institutes of Health.

Latest News

21st century curator

Even while he was doing his PhD in art history, Julien Domercq was not only getting involved in the British art scene, he was curating one of the biggest art exhibitions of the day. Julien [2013] had taken up a two-year entry-level contract at the National Gallery a couple of years into his PhD on […]

Understanding migrant stories

Two Gates Cambridge Scholars are collaborating on a new research, story-telling and advocacy enterprise which aims to record journeys of migration, amplify the voices of migrants and build empathy for the growing number of people who are displaced or have to leave their country. Noor Shahzad, founder at Migration Collective, became interested in the stories […]

Gates Cambridge Class of 2024 announced

The Gates Cambridge Class of 2024 made up of 75 outstanding new scholars has been officially announced. The Gates Cambridge scholarship programme is the University of Cambridge’s flagship international postgraduate scholarship programme. It was established through a US$210 million donation to the University of Cambridge from the Bill and Melinda Gates Foundation in 2000. Since […]

Addressing the mental health emergency

Mental health has been rising up the global health priority list over the last few years, but Covid accelerated it. Yet the resources available to those in crisis situations are few. Gates Cambridge Scholar Usama Mirza is addressing one particular gap in his home country of Pakistan, having recently launched Asia’s first mental health ambulance […]